Meeting Date: April 15, 2025 | 7:00–8:15 PM ET

Credit Available for this Activity: 1.25 CME

On-Demand: Available until December 31, 2025, or register for the enduring activity (available until May 7, 2028)

Program Schedule

The ACR Convergence Replay 2024 webinar series will include recorded sessions from ACR Convergence followed by a live Q&A with the presenters to answer your questions and provide further insights.

This session is about the latest advancements and challenges in the management of ANCA-associated vasculitis (AAV). Although treatment guidelines have become available, many questions persist about their specific application to different clinical scenarios and patient population with ANCA-associated vasculitis (AAV). In addition, recent evidence has reopened the debate about low versus standard dose glucocorticoids. An ongoing controversy about the use of plasmapheresis persists despite the findings of the PEXIVAS study. The use of avacopan has opened an opportunity for glucocorticoid minimization and remaining indications for cyclophosphamide are important to discuss.

Credit Claiming Information

To claim credit for the activity, learners must complete the following sections.

1. Pre-test
2. Post-test (to claim credit, a score of 70% or higher is required)
3. Activity evaluation & reflective statement (after completing this section, you will be able to claim credit and download a certificate)

Learners can claim credit one time. 

The deadline to claim CME credit and MOC points is December 31, 2025, at 11:59 PM ET.

View Claimed Credit: See your claimed credit on the My Learning page.

Download Certificate: Download your certificate in the Certificate section or on the My Certificates page.

30 days after completing the activity, you will receive an email with a request to complete the 30-day post-activity evaluation.

See full details about ACR’s CME and MOC on the CME & MOC page.